Fintech & Payments Taxation & Incentives in Israel

Israel is one of the few jurisdictions where a fintech or payments company can simultaneously access a reduced corporate tax rate, substantial R&D grants, capital gains exemptions for qualifying investors, and a licensing framework that does not impose prohibitive compliance costs on early-stage operators. The combination makes Israel structurally attractive for building a regional or global fintech hub, but only if the company correctly navigates the interaction between the Law for the Encouragement of Capital Investments (Chok le';idud hashka';ot), the Research and Development Law (Chok hameda vehatechnologia), and the standard Income Tax Ordinance (Pekudat mas hakhnasa). Misreading any one of these layers can eliminate the benefit entirely or trigger clawback obligations that exceed the original saving.

This article covers the principal tax incentives available to fintech and payments businesses in Israel, the conditions that must be satisfied to access each regime, the procedural steps and timelines involved, the interaction with licensing requirements under the Payment Services Law (Chok sherutei tashlum), and the most common strategic mistakes made by international operators entering the Israeli market.

---

The standard Israeli corporate tax rate is set under the Income Tax Ordinance and applies to all Israeli-resident companies and to permanent establishments of foreign companies. For most commercial entities, this rate is material and competitive by regional standards, though not exceptional on a global basis.

The real advantage for fintech and payments companies lies in the preferential regimes layered on top of the standard rate. The Law for the Encouragement of Capital Investments, as amended in its current consolidated form, creates two primary tracks relevant to technology companies: the Preferred Enterprise (Mifal muadaf) regime and the Preferred Technological Enterprise (Mifal muadaf technologi) regime. The latter was specifically designed to capture high-value IP-intensive businesses, which describes the majority of fintech and payments platforms.

Under the Preferred Technological Enterprise regime, a qualifying company pays a significantly reduced corporate tax rate on income derived from its qualifying intellectual property. The rate applicable in development zones designated by the Israeli government is lower still. For a payments company whose core product is proprietary software, a licensed algorithm, or a patented transaction processing method, a substantial portion of revenues can be attributed to qualifying IP, reducing the effective tax burden considerably below the headline rate.

The critical condition is that the IP must have been developed in Israel, or substantially developed in Israel, and the company must meet minimum R&D expenditure thresholds relative to total revenues. The Israel Innovation Authority (Rashut hahanovatsiya) plays a central role in certifying eligibility. A company that acquires IP from a related party abroad and then claims the preferential rate without genuine Israeli development activity will face challenge on both the tax and the IP ownership dimensions.

A non-obvious risk is that the preferential rate applies only to income derived from the qualifying IP. Revenue streams from payment processing fees that are not directly attributable to proprietary technology, or from float income on client funds, may fall outside the regime and be taxed at the standard rate. Structuring the revenue attribution correctly from day one is therefore not a formality but a substantive tax planning exercise.

---

The Israel Innovation Authority (IIA) administers the primary grant mechanism for technology companies, operating under the Research and Development Law. For fintech and payments companies, IIA grants represent a direct cash benefit that reduces the cost of building core technology infrastructure in Israel.

The IIA offers several grant tracks. The most relevant for an established fintech operator is the standard R&D grant, which reimburses a percentage of approved R&D expenditures. For companies meeting certain size and revenue criteria, the reimbursement rate is lower; for smaller or earlier-stage companies, the rate is higher. The grant is not a loan in the conventional sense, but it carries royalty repayment obligations: once the company generates revenues from the funded technology, it must repay the grant through royalties at a prescribed rate until the full grant amount is recovered, plus a premium.

The royalty obligation has a critical implication for fintech companies considering future M&A or IP transfers. Under the R&D Law, transferring IIA-funded IP outside Israel - whether through a sale, licensing arrangement, or corporate restructuring - requires IIA approval and typically triggers an accelerated repayment obligation that can be a multiple of the original grant. International acquirers of Israeli fintech companies frequently discover this obligation only during due diligence, at which point it becomes a significant negotiation point on price and structure.

The application process for IIA grants involves submitting a detailed technical and commercial plan to the IIA committee. Approval timelines vary by track but typically run between two and four months from submission to decision. The IIA evaluates both the technological novelty of the project and its commercial viability. A payments company proposing incremental improvements to existing infrastructure is less likely to succeed than one proposing genuinely novel approaches to transaction security, fraud detection, or cross-border settlement.

Practical scenario one: a mid-size European payments company establishes an Israeli R&D subsidiary to develop a proprietary fraud-scoring engine. It applies for IIA grants covering a portion of the subsidiary';s annual R&D budget. The grant reduces the effective cost of the Israeli operation, and the resulting IP qualifies for the Preferred Technological Enterprise rate on revenues attributed to the engine. The combined benefit is material. However, when the parent group later considers selling the Israeli subsidiary to a US strategic buyer, the IIA royalty obligation on the fraud-scoring IP must be quantified and factored into the transaction structure.

To receive a checklist on IIA grant eligibility and royalty obligations for fintech companies in Israel, send a request to info@vlolawfirm.com

---

The Law for the Encouragement of Research, Development and Technological Innovation in Industry, commonly known as the Angel Law (Chok hamala';akhim), provides capital gains tax exemptions for qualifying investors in early-stage Israeli technology companies. While this regime primarily benefits investors rather than the fintech company itself, it directly affects the company';s ability to raise capital from Israeli high-net-worth individuals and family offices, and it shapes the terms on which that capital is available.

Under the Angel Law, an individual investor who invests in a qualifying R&D company and holds the investment for a minimum period receives an exemption from Israeli capital gains tax on the appreciation. The qualifying company must be engaged in R&D activity approved by the IIA, must be an Israeli-resident company, and must meet size criteria at the time of investment. The investor must be an Israeli tax resident.

For a fintech or payments company raising seed or Series A capital in Israel, Angel Law eligibility is a meaningful competitive advantage in investor negotiations. It effectively increases the after-tax return to the investor without increasing the pre-money valuation, which benefits both sides. A common mistake is failing to obtain IIA certification of R&D activity before closing the investment round, which disqualifies the investor from the exemption retroactively.

The interaction between the Angel Law and the Preferred Technological Enterprise regime creates a structurally attractive environment for Israeli fintech companies at multiple stages. At the early stage, investors benefit from capital gains exemptions. At the growth stage, the company benefits from reduced corporate tax on IP income. At the exit stage, the combination of these factors - together with Israel';s network of tax treaties - can produce a tax-efficient outcome for both founders and investors, provided the structure has been correctly maintained throughout.

A non-obvious risk for international founders is that the Angel Law benefits apply only to Israeli tax residents. A foreign investor does not benefit from the Israeli capital gains exemption, though they may benefit from treaty provisions or their home jurisdiction';s participation exemption. Structuring a cap table that includes both Israeli and foreign investors therefore requires careful attention to the different tax positions of each class.

---

The Payment Services Law (Chok sherutei tashlum), which brought Israel';s payments regulation broadly into alignment with European PSD2 principles, created a licensing framework administered by the Bank of Israel (Bank Yisrael). The licensing categories cover payment initiation services, account information services, and payment instrument issuance, among others.

From a tax perspective, the licensing framework interacts with the incentive regimes in several ways that are not immediately obvious. First, a company operating without a required license is exposed to regulatory sanctions that can include fines and operational restrictions. Regulatory sanctions are not tax-deductible under the Income Tax Ordinance, and the legal costs of defending regulatory proceedings reduce the effective benefit of any tax incentive. Operating in a compliant manner is therefore a precondition for realising the full economic value of the tax incentives.

Second, the licensing process requires the company to demonstrate adequate capital and operational substance in Israel. This substance requirement, while primarily regulatory in nature, also supports the tax position. A company that maintains genuine management and control in Israel, employs qualified staff locally, and holds its core IP in Israel is in a much stronger position to defend its Preferred Technological Enterprise status against challenge by the Israel Tax Authority (Rashut hamas).

Third, the Payment Services Law imposes requirements on the handling of client funds, including segregation and safeguarding obligations. The income generated on segregated client funds - float income - is a significant revenue line for many payments companies. The tax treatment of this income depends on whether it is characterised as interest income, financial income, or operational income, and the characterisation affects both the applicable rate and the eligibility for preferential treatment. The Israel Tax Authority has not issued comprehensive guidance on this point, and the position must be established through careful legal and tax analysis at the outset of operations.

Practical scenario two: a UK-based payments company obtains a Payment Services Law license in Israel to serve the Israeli market and use Israel as a gateway to the wider region. It employs a team of developers and compliance officers in Tel Aviv. The company';s proprietary payment routing technology qualifies for the Preferred Technological Enterprise regime. However, a significant portion of its Israeli revenue comes from float on client funds held in Israeli bank accounts. The tax treatment of the float income requires a separate analysis and may not benefit from the preferential rate, increasing the blended effective tax rate above initial projections.

---

Transfer pricing is the area where Israeli fintech companies most frequently encounter unexpected tax exposure. The Income Tax Ordinance, read together with the Transfer Pricing Regulations (Takkanot mas hakhnasa - kvi';at me';hir), requires that transactions between related parties be conducted at arm';s length. For a fintech group with an Israeli R&D subsidiary, an offshore IP holding company, and operating entities in multiple jurisdictions, the transfer pricing analysis is complex and consequential.

The Israel Tax Authority has historically been active in challenging transfer pricing arrangements that it views as artificially shifting value out of Israel. The authority';s position, consistently maintained in administrative proceedings and before the courts, is that where genuine economic value is created in Israel through R&D activity, the Israeli entity should retain a commensurate share of the resulting profits. A structure that pays the Israeli R&D subsidiary a cost-plus fee while attributing the bulk of IP profits to an offshore holding company will face scrutiny.

The interaction with IIA grants adds a further dimension. If the Israeli entity has received IIA grants for R&D activity, the IIA';s position is that the resulting IP belongs, in an economic sense, to the Israeli ecosystem. Transferring that IP to an offshore holding company - even at a price determined by a transfer pricing study - requires IIA approval and triggers royalty obligations. A structure that is defensible from a pure transfer pricing perspective may still be non-compliant with the R&D Law.

A common mistake made by international fintech groups is to design the Israeli structure based on transfer pricing principles alone, without consulting the R&D Law framework. The two regimes operate in parallel and must be satisfied simultaneously. Failure to satisfy the R&D Law requirements can result in clawback of grants received, accelerated royalty obligations, and reputational damage with the IIA that affects future grant applications.

The arm';s length principle under the Transfer Pricing Regulations requires contemporaneous documentation. The Israel Tax Authority can request transfer pricing documentation as part of a routine audit, and the absence of documentation shifts the burden of proof to the taxpayer. For a fintech company with intercompany IP licensing arrangements, royalty payments to a parent, or cost-sharing agreements, preparing and maintaining this documentation is not optional.

To receive a checklist on transfer pricing documentation requirements for fintech IP structures in Israel, send a request to info@vlolawfirm.com

---

The economic case for establishing a fintech or payments operation in Israel rests on the combination of the Preferred Technological Enterprise rate, IIA grants, and access to a deep pool of technical talent. The combined benefit, properly structured, can reduce the effective tax burden on IP income to a level that is competitive with established IP holding jurisdictions, while simultaneously providing grant funding that reduces the cash cost of R&D.

The risk of inaction is concrete. A fintech company that enters the Israeli market without structuring its operations to qualify for the Preferred Technological Enterprise regime from the outset may find that retroactive restructuring is either impossible or prohibitively expensive. The regime requires that the IP be developed in Israel, which means the development activity must precede the IP, not follow it. A company that develops its core technology offshore and then attempts to migrate it to Israel will face both IIA restrictions on the grant side and transfer pricing challenges on the tax side.

Practical scenario three: a US fintech company acquires an Israeli startup that holds IIA-funded IP. The acquirer assumes that the Israeli entity';s tax position will continue unchanged post-acquisition. In practice, the change of control triggers a review by both the IIA and the Israel Tax Authority. The IIA may require renegotiation of the royalty repayment terms. The Tax Authority may challenge the valuation of the IP at the time of acquisition. The acquirer';s failure to conduct adequate pre-acquisition due diligence on these points results in a post-closing adjustment that materially affects the economics of the deal.

The cost of non-specialist mistakes in the Israeli fintech tax context is high. The interaction between the R&D Law, the Capital Investments Law, the Transfer Pricing Regulations, and the Payment Services Law creates a matrix of compliance obligations that requires coordinated legal and tax advice. A company that manages these streams separately - using a tax adviser for the corporate tax position, a regulatory adviser for the license, and a separate counsel for the IIA grant - risks gaps in the analysis that only become visible during an audit or a transaction.

The business economics of the decision to establish in Israel should be modelled on realistic assumptions about the timeline to IIA grant approval, the royalty repayment obligations on future revenues, the cost of maintaining transfer pricing documentation, and the regulatory compliance burden under the Payment Services Law. Lawyers'; fees for structuring a compliant Israeli fintech operation typically start from the low thousands of USD for discrete advisory work and scale significantly for full structural implementation. State and regulatory fees vary depending on the license category and the capital requirements applicable to the specific payments activity.

Comparing the alternatives: a fintech company considering Israel against other jurisdictions - such as Cyprus, Luxembourg, or Singapore - should evaluate not only the headline tax rate but the substance requirements, the grant availability, the talent pool, and the regulatory framework. Israel';s advantage lies in the combination of genuine grant funding and a deep technology ecosystem. Its disadvantage, relative to some offshore or low-substance jurisdictions, is that the benefits require real operational presence and cannot be achieved through a letterbox structure.

We can help build a strategy for entering the Israeli fintech market with a tax-efficient and compliant structure. Contact info@vlolawfirm.com to discuss your specific situation.

---

What is the most significant practical risk for a foreign fintech company claiming the Preferred Technological Enterprise regime in Israel?

The most significant risk is failing to establish that the qualifying IP was genuinely developed in Israel. The Israel Tax Authority examines the location of key development personnel, the substance of the Israeli entity';s R&D activity, and the consistency between the transfer pricing documentation and the actual operational facts. A company that employs a small team in Israel while the core development work is done abroad will struggle to defend the preferential rate. The risk is compounded if IIA grants have been received, because the IIA';s own records of the funded activity will be available to the Tax Authority and must be consistent with the tax position.

How long does it take to obtain IIA grant approval, and what happens if the company starts spending on R&D before approval is granted?

IIA grant approval for the standard R&D track typically takes between two and four months from submission of a complete application. R&D expenditure incurred before approval is granted is generally not eligible for reimbursement under the approved grant. A company that begins significant R&D spending in anticipation of approval and then receives a reduced grant - or a rejection - will have committed costs that are not recoverable from the IIA. The correct approach is to submit the application before committing major expenditure, or to structure the initial phase of activity as a preparatory stage that does not constitute the core of the funded project.

When should a fintech company in Israel consider replacing the Preferred Technological Enterprise regime with a different structure?

The Preferred Technological Enterprise regime is most valuable when a substantial portion of revenues is attributable to qualifying IP and the company maintains genuine R&D activity in Israel. If the company';s revenue mix shifts toward fee-based services that are not IP-derived, or if the company reduces its Israeli R&D headcount significantly, the proportion of income eligible for the preferential rate shrinks and the compliance cost of maintaining the regime may outweigh the benefit. In that scenario, a company should evaluate whether a simpler structure - potentially with a different jurisdictional mix - produces a better after-tax outcome. The decision requires a quantitative model that compares the preferential rate on qualifying income against the standard rate on total income, net of compliance costs.

---

Israel';s fintech and payments tax framework rewards companies that invest genuinely in Israeli R&D, maintain compliant operational substance, and structure their intercompany arrangements carefully from the outset. The Preferred Technological Enterprise regime, IIA grants, and the Angel Law create a layered incentive structure that is substantively competitive. The risks - transfer pricing exposure, IIA royalty obligations, and Payment Services Law compliance costs - are manageable with the right advice but can be material if ignored.

To receive a checklist on the full compliance and incentive framework for fintech and payments companies in Israel, send a request to info@vlolawfirm.com

Our law firm VLO Law Firms has experience supporting clients in Israel on fintech taxation, R&D incentive structuring, IIA grant applications, and Payment Services Law compliance matters. We can assist with designing the optimal corporate structure, preparing transfer pricing documentation, managing IIA interactions, and coordinating regulatory and tax positions across jurisdictions. To receive a consultation, contact: info@vlolawfirm.com